CA - Medexus Pharmaceuticals FQ3 revenue to increase 34% Y/Y

• Medexus Pharmaceuticals ( OTCQX:MEDXF ) ( TSX: MDP:CA ) said its FQ3 revenue is expected to be between $28.5M and $29.0M, an increase of 34% Y/Y and at least 3% Q/Q.
• The company said the primary drivers for the revenue increase were increases in net sales across the company's portfolio.
• Source: Press Release

For further details see: